<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04847817</url>
  </required_header>
  <id_info>
    <org_study_id>0011/2020/PR/SG/CNE</org_study_id>
    <secondary_id>CEI-10/2020</secondary_id>
    <nct_id>NCT04847817</nct_id>
  </id_info>
  <brief_title>Important Data on COVID-19 Profile in Africa</brief_title>
  <acronym>AIDCO</acronym>
  <official_title>Important Data on COVID-19 Profile in Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche Médicale de Lambaréné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European and Developing Countries Clinical Trials Partnership (EDCTP)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut de recherche en santé de surveillance épidémiologique et de formation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université des Sciences de la Santé</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Armauer Hansen Research Institute, Ethiopia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universität Tübingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre de Recherche Médicale de Lambaréné</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19)&#xD;
      infection to better define the period of infectiousness and transmissibility and to establish&#xD;
      biobanks of COVID-19 blood and mucosal samples.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study ,the participants will be enrolled sequentially in the COVID-19 care referral&#xD;
      centers. The infected hospitalized patient will be identified by the physicians in hospital.&#xD;
      After the patient has given his/her informed consent the permission will be sought from him&#xD;
      to approach his household contacts. The household contacts will be screened, and included in&#xD;
      the study.&#xD;
&#xD;
      Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all&#xD;
      ages and gender (40% minimum of female), will be enrolled upon receipt of written informed&#xD;
      consent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical and biological parameters of COVID-19</measure>
    <time_frame>14 days</time_frame>
    <description>Infection and disease progression - Pattern of virus transmission</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2 transmissibility</measure>
    <time_frame>14 days</time_frame>
    <description>proportion of household contact who will become positive for SARS-COV2 using PCR</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Coronavirus Infection</condition>
  <condition>Africa</condition>
  <arm_group>
    <arm_group_label>Index cases</arm_group_label>
    <description>Patients infected by SARS-Cov2 Polymerase Chain Reaction (PCR) and hospitalized in a referral center for COVID-19 .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Households cases</arm_group_label>
    <description>Household contacts of SARS-Cov2 hospitalized COVID-19 patients.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasopharyngeal mucosal Blood Urine Stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of volunteer COVID-19 patients hospitalized in referral&#xD;
        center for COVID-19 care as well as the household contacts of these hospitalized COVID-19&#xD;
        patients in Gabon, Senegal and Ethiopia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers,&#xD;
&#xD;
          -  Household contacts of hospitalized COVID-19 patient,&#xD;
&#xD;
          -  Provided signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ayôla Akim ADEGNIKA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherches Médicales de Lambaréné</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marielle BOUYOU-AKOTET</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université des Sciences de Santé</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ayôla Akim ADEGNIKA, PhD</last_name>
    <phone>+241 77989191</phone>
    <email>aadegnika@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elsy Mirna NNOH DANSOU, MSc</last_name>
    <phone>+241 77989191</phone>
    <email>elsydansou@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherches Médicales de Lammbaréné</name>
      <address>
        <city>Lambaréné</city>
        <state>Moyen- Ogooué</state>
        <zip>1437</zip>
        <country>Gabon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayôla Akim ADEGNIKA</last_name>
      <phone>+24177406464</phone>
      <email>aadegnika@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Recherches Médicales de Lambréné</name>
      <address>
        <city>Lambaréne</city>
        <country>Gabon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josiane HONKPEHEDJI</last_name>
      <phone>+2410 77989191</phone>
      <email>hyjosy@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jean Ronald EDOA</last_name>
      <phone>+2410 77989191</phone>
      <email>jronaldedoa@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Gabon</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronavirus infection</keyword>
  <keyword>SARS-CoV</keyword>
  <keyword>COVID-19</keyword>
  <keyword>Transmission</keyword>
  <keyword>Africa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Results from our COVID-19 AFRICA, AIDCO, project will be published in peer reviewed journals, seeking rapid and open access publication. This will be done as fast and widely as possible. Results will also be submitted and presented in any national, regional and international scientific meetings and congresses dedicated to COVID-19 online or face to face if, permitted. Before submission for publication or presentation, the review process outlined in the Consortium Agreement and agreed upon by all partners will be followed and care will be taken with respect to intellectual property protection.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

